MentalHealthDaily

Calorie Restriction (CR) Effects on Brain Gene Expression & Behavior in Rats (2023 Study)

by GLOOM

Calorie restriction (CR) is increasingly recognized for its potential benefits beyond just weight loss, including reducing anxiety, slowing aging, and mitigating the risk of obesity. Recent research focused on how both short-term and long-term CR affect behavior and gene expression in various brain regions, providing insights into the molecular underpinnings of these effects. Highlights: Behavioral …

Cannabidiol (CBD): Neuropsychiatric Uses, Mechanisms, Effects on Brain (2023 Review)

by GLOOM

Cannabidiol (CBD), a compound found in Cannabis sativa, has emerged as a substance of interest in the medical community due to its potential therapeutic benefits for various neurological and mental disorders. This comprehensive review examines the current scientific understanding of CBD’s effects on brain function, its potential as a therapeutic agent, and the ethical and …

Dietary Inflammatory Index (DII) vs. Mental Disorders (Anxiety & Depression) (2024 Study)

by GLOOM

The intricate relationship between dietary habits and mental health has gained significant attention. The Dietary Inflammatory Index (DII), a novel tool measuring diet’s inflammatory potential, has been used to help us better understand the connection between diet-realated inflammation and psychiatric disorders. Highlights: Diet & Mental Health: The DII helps in understanding how dietary choices can …

Optimal Dose of Exercise for Generalized Anxiety Disorder (GAD) in Aging Adults (2024 Study)

by GLOOM

Generalized Anxiety Disorder (GAD), a prevalent condition among older adults, may be significantly influenced by physical activity levels. Recent research from The Irish Longitudinal Study on Ageing (TILDA) provides groundbreaking insights into how even minimal physical activity can reduce the risk of GAD. Highlights: Minimal Dose for Maximum Benefit: Even low levels of moderate-to-vigorous physical …

Intranasal CRISPR Gene Editing for Anxiety via HTR2A Gene (5-HT2A Receptors) in Mice (2023 Study)

by GLOOM

The innovative use of CRISPR/Cas9 gene-editing technology has taken a leap forward in mental health treatment. A new study has demonstrated the successful noninvasive intranasal delivery of this technology to modify neural circuits in the central nervous system, targeting the HTR2A gene associated with anxiety and depression. This breakthrough offers a glimpse into the future …

Serotonin Transporter Genes (5-HTT) vs. Anxiety / Stress Behaviors & Neuroplasticity in Rats (2024 Study)

by GLOOM

In the intricate world of neuropsychiatric research, the role of serotonin in stress-related behaviors and disorders has long been a topic of fascination. Recent studies on rats have shed new light on this area, revealing intriguing ways in which genetics influence anxiety, depression, and neuroplasticity. Highlights: Serotonin Transporter Genes Influence Stress Behaviors: Rats with modified …

KNT-127 for Anxiety: Delta Opioid Receptor Agonist via PL-BLA Pathway (2023 Study)

by GLOOM

Recent scientific advancements have illuminated the crucial role of the prelimbic cortex to basolateral amygdala (PL-BLA) pathway in regulating anxiety-like behaviors. Utilizing cutting-edge optogenetic techniques and selective delta-opioid receptor (DOP) agonists, researchers have begun to decode the complex neural circuitry underlying anxiety disorders. Highlights: PL-BLA Pathway Significance: The connection between the prelimbic cortex (PL) and …